With NLP and ML features in the Apollo Intelligence Next-Generation Platform for Market Insights,
life science firms can gain significantly greater speed to insights and higher quality data
WATERTOWN MA March 20, 2024 —Konovo (formerly Apollo Intelligence), a leading provider of real-time data and insights to the healthcare and life science industries, was named a winner in the 2024 Artificial Intelligence Excellence Awards program by the Business Intelligence Group. Konovo’s Next-Generation Platform for Market Insights was recognized in the Natural Language Processing (NLP) category. With today’s fast pace and shifting market dynamics, and the risks associated with achieving anything less than optimal results, Konovo’s next-gen platform delivers a unique combination of high-quality data and speed to insight that is unmatched in the market.
In the past 12 months, Konovo’s next-gen platform increased speed-to-insights by 25%, improved physician member profile depth by 34%, and delivered eight game-changing NLP and machine learning (ML) and analytics-enabled features. These include a first of its kind adverse event feature using NLP to help flag open-end, verbatim survey answers that may represent adverse events that require FDA reporting.
“Konovo has a track record of leveraging technology to unlock new learning and transform life science market insights, and adding AI technologies within our platform continues this commitment,” said Daniel S. Fitzgerald, CEO and president of Konovo. “We are thrilled that our next-gen platform is being recognized for delivering fast, efficient, and high-quality market research at scale.”
About Konovo
Konovo’s mission is to accelerate health innovation to improve life. In 2019, Konovo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Konovo strengthened its global reach by acquiring Survey Healthcare Global, a market leader in first-party healthcare data collection and custom survey solutions. In 2024, Konovo acquired GlocalMind, a global technology-driven healthcare market research services and panel company, expanding its reach in Europe and APAC while enhancing follow-the-sun life science market insights efficiencies. Through these unique firms, Konovo provides access to two million healthcare stakeholders worldwide—physicians, KOLs, patients, caregivers, and allied healthcare professionals. Konovo’s 300+ employees support top global pharmaceutical and healthcare brands, market research agencies, and consultancies across 13 countries in the Americas, Europe, and Asia. Konovo is a portfolio company of Frazier Healthcare Partners. For more information about Konovo, please visit our website at https://konovo.com.
###
Contacts:
Mary Kae Marinac
PR Representative for Konovo
[email protected]
978-685-3136
